A double-blind, placebo-controlled study of the impact of galantamine on anterograde memory impairment during electroconvulsive therapy

Journal of ECT

Volumn 29, Issue 3, 2013, Pages 170-178

  Matthews, John D ^a,b   Siefert, Caleb J ^c,d   Blais, Mark A ^a   Park, Lawrence T ^b,d   Welch, Charles A ^a,b   Dubois, Christina M ^a   Van Nieuwenhuizen, Adrienne O ^a   Rooney, Kathryn O ^a   Seabrook, Rita C ^a   Durham, Lauren E ^a   Adams, Heather C ^a   Fava, Maurizio ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN DEARBORN   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Anterograde memory impairment; Electroconvulsive therapy; Galantamine

Indexed keywords

GALANTAMINE; PLACEBO;

ADULT; ARTICLE; ATTENTION; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MONITORING; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; HAMILTON SCALE; HEART RATE; HUMAN; LANGUAGE; MAJOR DEPRESSION; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; NAUSEA; NEUROPSYCHOLOGICAL TEST; PARALYSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REMISSION; REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS; SCHIZOAFFECTIVE PSYCHOSIS; SHORT TERM MEMORY; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; VOMITING; WECHSLER INTELLIGENCE SCALE;

AFFECT; AMNESIA, ANTEROGRADE; COGNITION; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; ELECTROCONVULSIVE THERAPY; FEMALE; GALANTAMINE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS;

EID: 84883560446     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e31828b3523     Document Type: Article

References (70)

1. Ng C, Schweitzer I, Alexopoulos P, et al. Efficacy and cognitive effects of right unilateral electroconvulsive therapy. J ECT. 2000;16:370-379
2. Pagnin D, de Queiroz V, Pini S, et al. Efficacy of ECT in depression: A meta-analytic review. J ECT. 2004;20:13-20
3. Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-analysis. Lancet. 2003;361:799-808
4. Coleman EA, Sackeim HA, Prudic J, et al. Subjective memory complaints prior to and following electroconvulsive therapy. Biol Psychiatry. 1996;39:346-356
5. Datka W, Siwek M, Dudek D, et al. Working memory disturbances in patients with major depression after ECT treatment [In Polish]. Psychiatr Pol. 2007;41:339-349
6. Feliu M, Edwards CL, Sudhakar S, et al. Neuropsychological effects and attitudes in patients following electroconvulsive therapy. Neuropsychiatr Dis Treat. 2008;4:613-617
7. Fraser LM, O'Carroll RE, Ebmeier KP. The effect of electroconvulsive therapy on autobiographical memory: A systematic review. J ECT. 2008;24:10-17
8. Kho KH, VanVreeswijk MF, Murre JM. A retrospective controlled study into memory complaints reported by depressed patients after treatment with electroconvulsive therapy and pharmacotherapy or pharmacotherapy only. J ECT. 2006;22:199-205
9. Malloy FW, Small IF, Miller MJ, et al. Changes in neuropsychological test performance after electroconvulsive therapy. Biol Psychiatry. 1982;17:61-67
10. Porter R, Heenan H, Reeves J. Early effects of electroconvulsive therapy on cognitive function. J ECT. 2008;24:35-39
11. Prudic J, Peyser S, Sackeim HA. Subjective memory complaints: A review of patient self-assessment of memory after electroconvulsive therapy. J ECT. 2000;16:121-132
12. Schat A, van den Broek WW, Mulder PG, et al. Changes in everyday and semantic memory function after electroconvulsive therapy for unipolar depression. J ECT. 2007;23:153-157
13. Steif BL, Sackeim HA, Portnoy S, et al. Effects of depression and ECT on anterograde memory. Biol Psychiatry. 1986;21:921-930
14. Taylor MA, Abrams R. Short-term cognitive effects of unilateral and bilateral ECT. Br J Psychiatry. 1985;146:308-311
15. Butterfield NN, Graf P, Macleod BA, et al. Propofol reduces cognitive impairment after electroconvulsive therapy. J ECT. 2004;20:3-9
16. D'Elia G. Memory changes after unilateral electroconvulsive therapy with different electrode positions. Cortex. 1976;12:280-289
17. Eschweiler GW, Vonthein R, Bode R, et al. Clinical efficacy and cognitive side effects of bifrontal versus right unilateral electroconvulsive therapy (ECT): A short-term randomised controlled trial in pharmaco-resistant major depression. J Affect Disord. 2007;101:149-157
18. Fujita A, Nakaaki S, Segawa K, et al. Memory, attention, and executive functions before and after sine and pulse wave electroconvulsive therapies for treatment-resistant major depression. J ECT. 2006;22:107-112
19. Geretsegger C, Nickel M, Judendorfer B, et al. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: A randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. J ECT. 2007;23:239-243
20. Ingram A, Saling MM, Schweitzer I. Cognitive side effects of brief pulse electroconvulsive therapy: A review. J ECT. 2008;24:3-9
21. Loo C, Sheehan P, Pigot M, et al. A report on mood and cognitive outcomes with right unilateral ultrabrief pulsewidth (0.3 ms) ECT and retrospective comparison with standard pulsewidth right unilateral ECT. J Affect Disord. 2007;103:277-281
22. Prudic J. Strategies to minimize cognitive side effects with ECT: Aspects of ECT technique. J ECT. 2008;24:46-51
23. Sackeim HA, Prudic J, Devanand DP, et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry. 2000;57:425-434
24. Andrade C, Sudha S, Venkataraman BV. Herbal treatments for ECS-induced memory deficits: A review of research and a discussion on animal models. J ECT. 2000;16:144-156
25. Dubovsky SL, Buzan R, Thomas M, et al. Nicardipine improves the antidepressant action of ECT but does not improve cognition. J ECT. 2001;17:3-10
26. Khan A, Mirolo MH, Mirolo HA, et al. Can ECT-induced cognitive effects be altered pharmacologically? Prog Neuropsychopharmacol Biol Psychiatry. 1993;17:861-873
27. Krueger RB, Sackeim HA, Gamzu ER. Pharmacological treatment of the cognitive side effects of ECT: A review. Psychopharmacol Bull. 1992;28:409-424
28. Pigot M, Andrade C, Loo C. Pharmacological attenuation of electroconvulsive therapyYinduced cognitive deficits: Theoretical background and clinical findings. J ECT. 2008;24:57-67
29. Prudic J, Fitzsimons L, Nobler MS, et al. Naloxone in the prevention of the adverse cognitive effects of ECT: A within-subject, placebo controlled study. Neuropsychopharmacology. 1999;21:285-293
30. Lerer B. Studies on the role of brain cholinergic systems in the therapeutic mechanisms and adverse effects of ECT and lithium. Biol Psychiatry. 1985;20:20-40
31. Lerer B, Stanley M, McIntyre I, et al. Electroconvulsive shock and brain muscarinic receptors: Relationship to anterograde amnesia. Life Sci. 1984;35:2659-2664
32. Bartus RT, Dean RL 3rd, Beer B, et al. The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982;217:408-414
33. Drachman D. Central cholinergic system and memory. In: Lipton M, DiMasco A, Killam K, eds. Psychopharmacology: A Generation of Progress. New York: Raven Press; 1979:651-662
34. Levin Y, Elizur A, Korczyn AD. Physostigmine improves ECT-induced memory disturbances. Neurology. 1987;37:871-875
35. Zink M, Sartorius A, Lederbogen F, et al. Electroconvulsive therapy in a patient receiving rivastigmine. J ECT. 2002;18:162-164
36. Prakash J, Kotwal A, Prabhu H. Therapeutic and prophylactic utility of the memory-enhancing drug donepezil hydrochloride on cognition of patients undergoing electroconvulsive therapy: A randomized controlled trial. J ECT. 2006;22:163-168
37. Geerts H, Sachak S, Grantham C, et al. Functional studies on brain levels and ache inhibition with galantamine and donepezil in rats, mice and rabbits. Neurobiol Aging. 2004;25:S187
38. Geerts H, Guillaumat PO, Grantham C, et al. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits. Brain Res. 2005;1033:186-193
39. Woodruff-Pak DS, Lander C, Geerts H. Nicotinic cholinergic modulation: Galantamine as a prototype. CNS Drug Rev Winter. 2002;8:405-426
40. Maelicke A, Samochocki M, Jostock R, et al. Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease. Biol Psychiatry. 2001;49:279-288
41. Oh MM, Wu WW, Power JM, et al. Galantamine increases excitability of CA1 hippocampal pyramidal neurons. Neuroscience. 2006;137:113-123
42. Albuquerque EX, Alkondon M, Pereira EF, et al. Properties of neuronal nicotinic acetylcholine receptors: Pharmacological characterization and modulation of synaptic function. J Pharmacol Exp Ther. 1997;280:1117-1136
43. Samochocki M, Hoffle A, Fehrenbacher A, et al. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors. J Pharmacol Exp Ther. 2003;305:1024-1036
44. Matthews JD, Blais M, Park L, et al. The impact of galantamine on cognition and mood during electroconvulsive therapy: A pilot study. J Psychiatr Res. 2008;42:526-531
45. Jones TG, Schinka JA, Vanderploeg RD, et al. 3MS normative data for the elderly. Arch Clin Neuropsychol. 2002;17:171-177
46. Randolph C, Tierney MC, Mohr E, et al. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary clinical validity. J Clin Exp Neuropsychol. 1998;20:310-319
47. Gold JM, Queern C, Iannone VN, et al. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: Sensitivity, reliability, and validity. Am J Psychiatry. 1999;156:1944-1950
48. Gontkovsky S, Beatty W, Mold J. Repeatable battery for the assessment of neuropsychological status in a normal, geriatric sample. Clinical Gerontologist. 2004;27:79-86
49. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48:314-318
50. Wechsler D. WASI: Wechsler Abbreviated Scale of Intelligence. San Antonio, TX: The Psychological Corporation; 1994
51. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62
52. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville, MD: National Institute of Mental Health; 1976
53. Nobler MS, Sackeim HA. ECT stimulus dosing: Relations to efficacy and adverse events. In: Coffey CE, ed. The Clinical Science of Electroconvulsive Therapy. Arlington, VA: American Psychiatric Publishing; 1993:29-52
54. Sackeim HA, Decina P, Portnoy S, et al. Studies of dosage, seizure threshold, and seizure duration in ECT. Biol Psychiatry. 1987;22:249-268
55. Sackeim HA, Prudic J, Devanand DP, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med. 1993;328:839-846
56. Quante A, Luborzewski A, Brakemeier EL, et al. Effects of 3 different stimulus intensities of ultrabrief stimuli in right unilateral electroconvulsive therapy in major depression: A randomized, double-blind pilot study. J Psychiatr Res. 2011;45:174-178
57. Fisher RS, Bortz JJ, Blum DE, et al. A pilot study of donepezil for memory problems in epilepsy. Epilepsy Behav. 2001;2:330-334
58. Losev NA, Tkachenko EI. Effect of N- and M-cholinergic-potentiating and cholinergic-blocking agents on the epileptogenesis of a penicillin focus in the dorsal hippocampus [in Russian]. Biull Eksp Biol Med. 1986;101:436-438
59. Rupreht J, Dworacek B, Ducardus R, et al. The involvement of the central cholinergic and endorphinergic systems in the nitrous oxide withdrawal syndrome in mice. Anesthesiology. 1983;58:524-526
60. Turski L, Ikonomidou C, Turski WA, et al. Review: Cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: A novel experimental model of intractable epilepsy. Synapse. 1989;3:154-171
61. Shrout PE, Bolger N. Mediation in experimental and nonexperimental studies: New procedures and recommendations. Psychol Methods. 2002;7:422-445
62. Amos (Version 7.0) Computer Program [computer program]. Chicago, IL: SPSS Inc; 2006
63. Woodruff-Pak DS, Vogel RW, Wenk GL. Galantamine: Effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning. Proc Natl Acad Sci U S A. 2001;98:2089-2094
64. Sackeim HA, Portnoy S, Neeley P, et al. Cognitive consequences of low-dosage electroconvulsive therapy. Ann N Y Acad Sci. 1986;462:326-340
65. Akaike A, Takada-Takatori Y, Kume T, et al. Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: Role of alpha4 and alpha7 receptors in neuroprotection. J Mol Neurosci. 2010;40:211-216
66. Hamberger MJ, Palmese CA, Scarmeas N, et al. A randomized, double-blind, placebo-controlled trial of donepezil to improve memory in epilepsy. Epilepsia. 2007;48:1283-1291
67. Boman B. Concurrent use of ECT and cholinesterase inhibitor medications. Aust N Z J Psychiatry. 2002;36:816
68. Janowsky DS, el-Yousef MK, Davis JM, et al. A cholinergic-adrenergic hypothesis of mania and depression. Lancet. 1972;2:632-635
69. Wechsler D. Wechsler Memory Scale. San Antonio, TX: The Psychological Corporation; 1945
70. Delis D, Kramer J, Kaplan E, et al. California Verbal Learning Test, Adult Version. San Antonio, TX: The Psychological Corporation; 1987